Is there or is there not a place for anti-interferon antibodies in the decision making of multiple sclerosis treatment optimisation?

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/FFCB30EE.svg?ark=w1%2F20260515%2FFFCB30EE)](https://nobleid.org/work/w1/20260515/FFCB30EE)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors